The difference between calculated values and observed values at observation well. by Haibo Li (629817)

The octanoylcarnitine level was significantly higher in estrogen receptor (ER)- and progesterone receptor (PR)-expressing tumors, but no significant difference was observed according to HER-2 expression. by Jiwon Park (2189989)

“…<p>The octanoylcarnitine level was significantly higher in estrogen receptor (ER)- and progesterone receptor (PR)-expressing tumors, but no significant difference was observed according to HER-2 expression.…”

Classification results for different observation windows. by Steven J. Krieg (12981584)

Differences between observed and predicted deaths (dotted line). by Mohammad Sorowar Hossain (5346422)

Mean ratings (with 95% confidence intervals) and significant differences between the four visual displays. by Nádia Moura (14761457)

Difference between observed and expected number of significant pathways arising from Gene Ontology Biological Process categories. by Ryan Sun (4285636)

“…<p>For a given phenotype, expected number is equal to the percentage of all tested pathways belonging to a category multiplied by the total number of significant pathways. The difference between observed and expected counts is expressed as a percentage of the expected number. …”

ModTPA differences in radiographic measurements between observers. by Geoffrey Pagès (13242833)

Differences in bone healing grade measurements between observers. by Geoffrey Pagès (13242833)

PreTPA differences in radiographic measurements between observers. by Geoffrey Pagès (13242833)

Two refined cell type composition with statistically significant differences across the CC strains. by Jieun Park (2560948)

Subjects:

Comparison of plasma cytokine levels between CRC patients and controls, significant differences were observed by multiple linear regression analysis. by Masaki Yamaguchi (668737)

“…<p>Comparison of plasma cytokine levels between CRC patients and controls, significant differences were observed by multiple linear regression analysis.…”

Intersection of significant DMRs. by Heather M. Brockway (7841153)

Subjects:

Average abnormal returns for different outcome types on various significant dates. by Manish Singh (352678)

Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

Different observed angle polarization images. by Hongyu Sun (176244)

Subjects:

Over representation analysis of significant metabolites. by Abishek Arora (13815757)

Subjects:

Comparison of significant mean shape differences between the techno-structural groups. by Marina González-Varas (20496415)

Subjects:

Incidences of clinically significant post-extraction bleeding and their difference. by Iwabuchi Hiroshi (12368654)

Subjects:

Brain regions with significant mouse strain differences in DTI measures in the adult cohort. by Anna L. Farmer (17830867)

Indicator loading of the observed variables. by María Salomé Ochoa Rico (12102319)